A CRC Trial of Rituximab in Combination With Sargramostim (GM-CSF) in Patients With Chronic Lymphocytic Leukemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 12 Aug 2014 Biomarkers information updated
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2010 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.